Inhibition of STAT3-interacting protein 1 (STATIP1) promotes STAT3 transcriptional up-regulation and imatinib mesylate resistance in the chronic myeloid leukemia. This evidence concerns the gene STAT3 and chronic myelogenous leukemia, BCR-ABL1 positive.